(4-051) Gastrointestinal Adverse Effects Associated with the Use of Intravenous Oliceridine Compared to Intravenous Hydromorphone or Fentanyl in Acute Pain Management Utilizing Indirect Treatment Comparison Methods

Monday, December 5, 2022

2:00 PM – 3:30 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Pain Management/Palliative Care

Co-Author(s): Diana I. Brixner, Gary M. Oderda, Todd L. Wandstrat

Primary Author(s)

Joseph E. Biskupiak, PhD, MBA
Research Professor
University of Utah College of Pharmacy, Utah